Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study) von Måseide, Ragnhild J., Berntorp, Erik, Astermark, Jan, Olsson, Anna, Bruzelius, Maria, Frisk, Tony, Nummi, Vuokko, Lassila, Riitta, Strandberg, Karin, Tjønnfjord, Geir E., Holme, Pål A.

Volltext

Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes von Nummi, Vuokko, Hiltunen, Leena, Szanto, Timea, Poikonen, Eira, Lehtinen, Anna‐Elina

Volltext

Switching from standard to extended half‐life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics von Nummi, Vuokko, Lehtinen, Anna‐Elina, Iorio, Alfonso, Szanto, Timea, Lassila, Riitta

Volltext

Acquired Haemophilia A in four north European countries: survey of 181 patients von Lindahl, Rickard, Nummi, Vuokko, Lehtinen, Anna‐Elina, Szanto, Timea, Hiltunen, Leena, Olsson, Anna, Glenthoej, Andreas, Chaireti, Roza, Vaide, Ines, Funding, Eva, Zetterberg, Eva

Volltext

Health‐related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study) von Måseide, Ragnhild J., Berntorp, Erik, Astermark, Jan, Olsson, Anna, Bruzelius, Maria, Frisk, Tony, Nummi, Vuokko, Lassila, Riitta, Tjønnfjord, Geir E., Holme, Pål A.

Volltext

Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study von Måseide, Ragnhild J., Berntorp, Erik, Astermark, Jan, Olsson, Anna, Bruzelius, Maria, Frisk, Tony, Nummi, Vuokko, Lassila, Riitta, Tjønnfjord, Geir E., Holme, Pål A.

Volltext

Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life‐threatening gastrointestinal bleed von Nummi, Vuokko, Lehtinen, Elina, Mäkipernaa, Anne, Szanto, Timea, Lassila, Riitta

Volltext

No difference in quality of life between persons with severe haemophilia A and B von Kihlberg, Kristina, Baghaei, Fariba, Bruzelius, Maria, Funding, Eva, Andre Holme, Pål, Lassila, Riitta, Nummi, Vuokko, Ranta, Susanna, Gretenkort Andersson, Nadine, Berntorp, Erik, Astermark, Jan

Volltext

Factor IX antibodies and tolerance in hemophilia B in the Nordic countries – The impact of F9 variants and complications von Kihlberg, Kristina, Baghaei, Fariba, Bruzelius, Maria, Funding, Eva, Holme, Pål Andre, Lassila, Riitta, Martin, Myriam, Nummi, Vuokko, Ranta, Susanna, Strandberg, Karin, Andersson, Nadine Gretenkort, Berntorp, Erik, Astermark, Jan

Volltext

Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study von Måseide, Ragnhild J., Berntorp, Erik, Astermark, Jan, Hansen, Jessica, Olsson, Anna, Bruzelius, Maria, Frisk, Tony, Aspdahl, Magnus, Nummi, Vuokko, Tjønnfjord, Geir E., Holme, Pål A.

Volltext

Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation von Måseide, Ragnhild J., Berntorp, Erik, Nummi, Vuokko, Lassila, Riitta, Tjønnfjord, Geir E., Holme, Pål A.

Volltext

Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B‐NORD study von Kihlberg, Kristina, Baghaei, Fariba, Bruzelius, Maria, Funding, Eva, Andre Holme, Pål, Lassila, Riitta, Nummi, Vuokko, Ranta, Susanna, Osooli, Mehdi, Berntorp, Erik, Astermark, Jan

Volltext

Sixth Åland Island Conference on von Willebrand disease von Berntorp, Erik, Trakymienė, Sonata S., Federici, Augusto B., Holstein, Katharina, Corrales‐Medina, Fernando F., Pierce, Glenn F., Srivastava, Alok, Prondzinski, Mario von Depka, Johnsen, Jill M., Zupan, Irena P., Halimeh, Susan, Nummi, Vuokko, Roberts, Jonathan C.

Volltext

Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed von Nummi, Vuokko, Lehtinen, Elina, Mäkipernaa, Anne, Szanto, Timea, Lassila, Riitta

Volltext